Steven Kheloussi, PharmD, explains how care coordination and transparent policies can improve MS treatment adherence, ...

EHR validation in 406,230 “relaxed” and 127,151 “strict” patients showed stable PREVENT discrimination across sexes, ...

IGHV mutational status has long been used by clinicians to predict how CLL will behave and when treatment may be needed. 2 ...

A breast cancer diagnosis doesn't land only on the patient, but rather it ripples through an entire household. In this ...

A 1000 mg ×2 induction regimen followed by maintenance every 6–12 months was associated with near-elimination of relapse ...

Prior authorization was rated a major burden by 32% of insured adults and the single greatest barrier by 34%, surpassing ...

The 340B Drug Pricing Program remains one of the most important structural supports for health systems across the US, ...

Wakely’s insurer-based dataset covering ~80% of Marketplace enrollment found approximately 1 in 7 new-year enrollees did not ...

A new case-control study published in JAMA Cardiology demonstrates that molecular imaging using gallium-68–labeled fibroblast ...

Embedded supportive care programs deliver measurable improvements, but fee-for-service economics prevent scaling because ...

Midterm messaging is likely to center on health care costs, with Republicans emphasizing DTC drug models and MFN pricing ...

John Barkett, MBA, discusses recent regulatory proposals to make massive health plan price files more usable. Price ...